Review Article
[Retracted] NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
| NLR Family | N Terminus | NLR members (HGNC symbols) | Aliases | Human | Mouse |
| NLRA | AA | CIITA | | NLRA; MHC2TA; C2TA | | Cllta | Nlra; MHC2TA; C2TA C2TA |
| NLRB | BID | NAIP | | NLRB1; BIRC1; CLR5.1 | | Naip1 | Birc1a | | Naip2 | Birc1b | | Naip3 | Birc1c | | Naip4 | Birc1d | | Naip5 | Birc1e | | Naip6 | Birc1f | | Naip7 | Birc1g |
| NLRC | CARD | NOD1 | | NLRC1; CARD4; CLR7.1 | | NOD1 | Nlrc1; Card4 | NOD2 | | NLRC2; CARD15; CD; BLAU; IBD1; PSORAS1; CLR16.3 | | NOD2 | Nlrc2; Card15 | NLRC3 | | NOD3; CLR16.2 | | NLRC3 | CLR16.2 | NLRC4 | | CARD12; CLAN; CLR2.1; IPAF | | NLRC4 | Card12; CLAN; Ipaf | NLRC5 | | NOD27; CLR16.1 |
| NLRP | PYD | NLRP1 | | NALP1; DEFCAP; NAC; CARD7; CLR17.1 | | Nlrp1a | NALP1a | | Nlrp1b | NALP1b | | Nlrp1c | NALP1c | NLRP2 | | NALP2; PYPAF2; NBS1; PAN1; CLR19.9 | | Nlrp2 | Pypaf2; Nbs1; Pan1 | NLRP3 | | CIAS1; PYPAF1; Cryopyrin; NALP3; CLR1.1 | | Nlrp3 | Cias1; Pypaf1; Cryopyrin; Nalp3; Mmig1 | NLRP4 | | NALP4; PYPAF4; PAN2; RNH2; CLR19.5 | | Nlrp4a | Nalp4a; Nalp-eta; Nalp9D | | Nlrp4b | Nalp4b; Nalp-gamma; Nalp9E | | Nlrp4c | Nalp4c; Nalp-alpha; Rnh2 | | Nlrp4d | Nalp4d; Nalp-beta | | Nlrp4e | Nalp4e; Nalp-epsilon | | Nlrp4f | Nalp4f; Nalp-kappa; Nalp9F | | Nlrp4g | Nalp4g | NLRP5 | | NALP5; PYPAF8; MATER; PAN11; CLR19.8 | | Nlrp5 | Mater; Op1 | NLRP6 | | NALP6; PYPAF5; PANS; CLR11.4 | | Nlrp6 | | NLRP7 | | NALP7; PYPAF3; NOD12; PAN7; CLR19.4 | NLRP8 | | NALP8; PAN4; NOD16; CLR19.2 | NLRP9 | | NALP9; NOD6; PAN12; CLR19.1 | | Nlrp9a | Nalp9a; Nalp-theta | | Nlrp9b | Nalp9b; Nalp-delta | | Nlrp9c | Nalp9c; Nalp-zeta | NRLP10 | | NALP10; PAN5; NOD8; PYNOD; CLR11.1 | | Nlrp10 | Nalp10; Pynod | NRLP11 | | NALP11; PYPAF6; NOD17; PAN10; CLR19.6 | NRLP12 | | NALP12; PYPAF7; Monarch1; RNO2; PAN6; CLR19.3 | | Nlrp12 | Nalp12 | NRLP13 | | NALP13; NOD14; PAN13; CLR19.7 | NRLP14 | | NALP14; NOD5; PAN8; CLR11.2 | | Nlrp14 | Nalp14; Nalp-iota; GC- LRR | NLRX1 | DED | | | NOD9; CLR11.3 |
|
|